Deltagen Inc
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorpo… Read more
Market Cap & Net Worth: Deltagen Inc (DGEN)
Deltagen Inc (PINK:DGEN) has a market capitalization of $0.92 ($0.92) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51524 globally and #16173 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Deltagen Inc's stock price $0.00 by its total outstanding shares 9207 (9.21K).
Deltagen Inc Market Cap History: 2015 to 2025
Deltagen Inc's market capitalization history from 2015 to 2025. Data shows change from $55.24 to $0.92 (-35.11% CAGR).
Deltagen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Deltagen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Deltagen Inc's market cap is 0.00 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $55.24 | $770.00K | -$46.00K | 0.00x | N/A |
Competitor Companies of DGEN by Market Capitalization
Companies near Deltagen Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Deltagen Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Deltagen Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Deltagen Inc's market cap moved from $55.24 to $ 0.92, with a yearly change of -35.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $0.92 | 0.00% |
| 2024 | $0.92 | 0.00% |
| 2023 | $0.92 | 0.00% |
| 2022 | $0.92 | 0.00% |
| 2021 | $0.92 | -97.14% |
| 2020 | $32.22 | +1650.00% |
| 2018 | $1.84 | -80.00% |
| 2017 | $9.21 | +900.00% |
| 2016 | $0.92 | -98.33% |
| 2015 | $55.24 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Deltagen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $0.92 USD |
| MoneyControl | $0.92 USD |
| MarketWatch | $0.92 USD |
| marketcap.company | $0.92 USD |
| Reuters | $0.92 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.